Showing results (91-100 of 140) with videos related to

Sort By:
Pageof 14
The Journal of Experimental Medicine|September 1, 1993
Expression of a functional c-kit receptor on a subset of natural killer cellsM E Matos, G S Schnier, M S Beecher, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|December 1, 2012
Antinociceptive and antiedematogenic effects of the hydroalcoholic extract and coumarin from Torresea cearensis Fr. AllL K Leal, M E Matos, F J Matos, et al.
Immunity, Inflammation and Disease|November 29, 2022
Clinical efficacy of synbiotics in children with allergic rhinitis: An observational cohort study from a private medical center in PeruCesar A Galvan Calle, Cecilia Díaz Vásquez, Ricardo Muñoz Leon, et al.
Materials (Basel, Switzerland)|December 9, 2023
Experimental Study of Drilling Damage Outcomes in Hybrid Composites with Waste Micro-InclusionsLuis M P Durão, João E Matos, João Alves, et al.
Materials (Basel, Switzerland)|April 24, 2025
A Statistical Study on the Influence of Drilling Process in Delamination Observed in Composite PlatesHugo R C Cerqueira, João E Matos, José L Esteves, et al.
Current Medical Research and Opinion|November 28, 2019
Factors associated with the discontinuation of dipeptidyl peptidase-4 inhibitors (DPP-4is) after initiation of insulinGail Fernandes, Joana E Matos, Dena H Jaffe, et al.
Plos One|February 8, 2014
c-Myc regulates cell proliferation during lens developmentGabriel R Cavalheiro, Gabriel E Matos-Rodrigues, Anielle L Gomes, et al.
Oncology Reports|May 19, 2011
Increased levels of urinary basic fibroblast growth factor in bladder cancer patientsL Puricelli, M Delorenzo, A Eijan, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 4, 2012
Vitreous surgery impact in glaucoma development in liver transplanted familial amyloidosis ATTR V30M Portuguese patientsNuno M Beirão, Maria E Matos, Maria J Meneres, et al.
Annals of Hematology|January 1, 2022
The burden of illness in patients with paroxysmal nocturnal hemoglobinuria receiving treatment with the C5-inhibitors eculizumab or ravulizumab: results from a US patient surveyDavid Dingli, Joana E Matos, Kerri Lehrhaupt, et al.
Pageof 14